Hitoshi Tsuda

27.4k total citations · 1 hit paper
610 papers, 20.2k citations indexed

About

Hitoshi Tsuda is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Hitoshi Tsuda has authored 610 papers receiving a total of 20.2k indexed citations (citations by other indexed papers that have themselves been cited), including 263 papers in Oncology, 200 papers in Cancer Research and 147 papers in Molecular Biology. Recurrent topics in Hitoshi Tsuda's work include Breast Cancer Treatment Studies (142 papers), Breast Lesions and Carcinomas (94 papers) and HER2/EGFR in Cancer Research (84 papers). Hitoshi Tsuda is often cited by papers focused on Breast Cancer Treatment Studies (142 papers), Breast Lesions and Carcinomas (94 papers) and HER2/EGFR in Cancer Research (84 papers). Hitoshi Tsuda collaborates with scholars based in Japan, United States and United Kingdom. Hitoshi Tsuda's co-authors include Setsuo Hirohashi, Osamu Matsubara, Johji Inazawa, Masashi Takano, Issei Imoto, Seiichi Tamai, Koji Tsuta, Takashi Fukutomi, Yae Kanai and Sohei Yamamoto and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Hitoshi Tsuda

595 papers receiving 19.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells

2014 582 citations Ryou-u Takahashi, Masayuki Yoshida et al. profile →

Peers

Countries citing papers authored by Hitoshi Tsuda

Since Specialization

Citations

This map shows the geographic impact of Hitoshi Tsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Tsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Tsuda more than expected).

Fields of papers citing papers by Hitoshi Tsuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Tsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Tsuda. The network helps show where Hitoshi Tsuda may publish in the future.

Co-authorship network of co-authors of Hitoshi Tsuda

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Tsuda. A scholar is included among the top collaborators of Hitoshi Tsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Tsuda. Hitoshi Tsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study 2025 ·Journal of Gynecologic Oncology ·Shin Nishio, Kimio Ushijima, Mitsuya Ishikawa, Hideki Tokunaga, Koji Horie, Satoshi Yamaguchi, Shiro Suzuki, Hideaki Yahata, Hitoshi Tsuda, Toyomi Satoh	0
2	Radiofrequency ablation without excision for breast cancer: 5-year results of ipsilateral breast tumor recurrence-free survival in the RAFAELO study (NCCH1409). 2024 ·Journal of Clinical Oncology ·Takayuki Kinoshita, Shin Takayama, Masato Takahashi, Tomomi Fujisawa, (unknown), Tadahiko Shien, Manabu Futamura, Mitsuya Ito, Mina Takahashi, (unknown), Kenichi Watanabe, Tatsuya Onishi, Masayuki Yoshida, Hitoshi Tsuda, Taro Shibata, (unknown), (unknown)	0
3	Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO) 2022 ·Journal of Gynecologic Oncology ·Yusuke Kobayashi, Kenta Masuda, (unknown), Kazuhiro Takehara, Hitoshi Tsuda, Yoh Watanabe, Katsutoshi Oda, Satoru Nagase, Masaki Mandai, Aikou Okamoto, Nobuo Yaegashi, Mikio Mikami, Takayuki Enomoto, Daisuke Aoki, Hidetaka Katabuchi	3
4	Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer 2022 ·Cancer Science ·(unknown), Shuhei Komatsu, Takuma Ohashi, Jun Kiuchi, Hajime Kamiya, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Takeshi Kubota, Kazuma Okamoto, Hitoshi Fujiwara, Hitoshi Tsuda, Eigo Otsuji	9
5	Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer 2019 ·BMC Cancer ·(unknown), Kazunori Nagasaka, Hitoshi Tsuda, Yasuyuki Ishii, Masaru Sakamoto, Yoshihiro Kikuchi, (unknown), (unknown), Haruko Hiraike, Takayuki Kobayashi, Takayuki Kinoshita, Yae Kanai, Tatsuhiro Shibata, Issei Imoto, Johji Inazawa, Osamu Matsubara, Takuya Ayabe	9
6	Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin 2017 ·Medical Oncology ·Hiroaki Soyama, Morikazu Miyamoto, Masashi Takano, Tadashi Aoyama, (unknown), (unknown), (unknown), (unknown), K. Kato, Tomoyuki Yoshikawa, (unknown), Hitoshi Tsuda, Kenichi Furuya	7
7	The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma 2016 ·Oncogene ·Tomoki Muramatsu, (unknown), Seiya Imoto, Rui Yamaguchi, Hitoshi Tsuda, Tatsuyuki Kawano, Naoto Fujiwara, Masayuki Morishita, Satoru Miyano, Johji Inazawa	30
8	Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity 2015 ·Cancer Research ·Tatsuya Ishiguro, Ai Sato, Hirokazu Ohata, Yoshinori Ikarashi, Ryou-u Takahashi, Takahiro Ochiya, Masayuki Yoshida, Hitoshi Tsuda, Takashi Onda, Tomoyasu Kato, Takahiro Kasamatsu, Takayuki Enomoto, Kenichi Tanaka, Hitoshi Nakagama, Koji Okamoto	58
9	Oncogenic Ras/ERK Signaling Activates CDCP1 to Promote Tumor Invasion and Metastasis 2014 ·Molecular Cancer Research ·Takamasa Uekita, Satoko Fujii, Yuri Miyazawa, Reika Iwakawa, Mako Narisawa‐Saito, Katsuhiko Nakashima, Koji Tsuta, Hitoshi Tsuda, Tohru Kiyono, Jun Yokota, Ryuichi Sakai	55
10	p53 expression in pretreatment specimen predicts response to neoadjuvant chemotherapy including anthracycline and taxane in patients with primary breast cancer. 2013 ·PubMed ·Tadahiko Shien, Takayuki Kinoshita, Kunihiko Seki, Miwa Yoshida, Takashi Hojo, Chikako Shimizu, Naruto Taira, Hiroyoshi Doihara, Sadako Akashi‐Tanaka, Hitoshi Tsuda, Yasuhiro Fujiwara	4
11	Histological Grading of Ovarian Clear Cell Adenocarcinoma 2012 ·International Journal of Gynecological Pathology ·Sohei Yamamoto, Hitoshi Tsuda, Hideyuki Shimazaki, Masashi Takano, Tomoyuki Yoshikawa, Kazuo Kuzuya, Hiroshi Tsuda, Hirohisa Kurachi, Junzo Kigawa, Yoshihiro Kikuchi, Toru Sugiyama, Osamu Matsubara	9
12	Clear Cell Adenocarcinoma With a Component of Poorly Differentiated Histology 2011 ·International Journal of Gynecological Pathology ·Sohei Yamamoto, Hitoshi Tsuda, Hideyuki Shimazaki, Masashi Takano, Tomoyuki Yoshikawa, Kazuo Kuzuya, Hiroshi Tsuda, Hirohisa Kurachi, Junzo Kigawa, Yoshihiro Kikuchi, Toru Sugiyama, Osamu Matsubara	9
13	Validation of the Histologic Grading for Ovarian Clear Cell Adenocarcinoma 2011 ·International Journal of Gynecological Pathology ·Sohei Yamamoto, Atsuko Kasajima, Masashi Takano, Nobuo Yaegashi, Hiroyuki Fujiwara, Kazuo Kuzuya, Junzo Kigawa, Hiroshi Tsuda, Hirohisa Kurachi, Yoshihiro Kikuchi, Toru Sugiyama, Hitoshi Tsuda, Takuya Moriya	13
14	Frequent Inactivation of a Putative Tumor Suppressor, Angiopoietin-Like Protein 2, in Ovarian Cancer 2008 ·Cancer Research ·(unknown), Hitoshi Tsuda, Ken‐ichi Kozaki, Yae Kanai, Takahiro Kasamatsu, Kazuo Sengoku, Setsuo Hirohashi, Johji Inazawa, Issei Imoto	48
15	Expression and Gene Amplification of Actinin-4 in Invasive Ductal Carcinoma of the Pancreas 2008 ·Clinical Cancer Research ·Satoru Kikuchi, Kazufumi Honda, Hitoshi Tsuda, Nobuyoshi Hiraoka, Issei Imoto, Tomoo Kosuge, (unknown), Kaoru Onozato, Miki Shitashige, Umio Yamaguchi, Masaya Ono, Akihiko Tsuchida, Tatsuya Aoki, Johji Inazawa, Setsuo Hirohashi, Tesshi Yamada	96
16	What Causes Discrepancies in HER2 Testing for Breast Cancer? 2008 ·American Journal of Clinical Pathology ·Shinobu Umemura, R. Yoshiyuki Osamura, Futoshi Akiyama, Keiichi Honma, Masafumi Kurosumi, Hironobu Sasano, Satoshi Toyoshima, Hitoshi Tsuda, Josef Rüschoff, Goi Sakamoto	31
17	Promoter Hypermethylation Contributes to Frequent Inactivation of a Putative Conditional Tumor Suppressor Gene Connective Tissue Growth Factor in Ovarian Cancer 2007 ·Cancer Research ·(unknown), Hitoshi Tsuda, Yae Kanai, Takahiro Kasamatsu, Kazuo Sengoku, Setsuo Hirohashi, Johji Inazawa, Issei Imoto	68
18	A CASE OF SUBMUCOSAL BASALOID-SQUAMOUS CARCINOMA OF THE ESOPHAGUS WITH LIVER METASTASIS 2005 ·Acta gastro-enterologica belgica ·Daisaku Morita, Mikihiko Kimura, Eiji Shinto, Hidekazu Sugasawa, Takefumi Uchida, Takashi Ichikura, Hidetaka Mochizuki, Hitoshi Tsuda, Osamu Matsubara	2
19	Microinvasive Breast Carcinoma with Extensive Involvement of Level III Axillary Lymph Nodes: a Case Report 1998 ·Japanese Journal of Clinical Oncology ·Kenichi Fujii, Takashi Fukutomi, Hitoshi Tsuda, Sadako Akashi‐Tanaka, Takeshi Nanasawa, Yae Kanai, Yukio Muramatsu	2
20	Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. 1989 ·PubMed ·Hitoshi Tsuda, S Hirohashi, Yukío Shimosato, T Hirota, Shoichiro Tsugane, Hiroshi Yamamoto, Noriyuki Miyajima, K Toyoshima, Tadashi Yamamoto, Jun Yokota	276

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact